The legal pressure on Tempus—which uses its massive trove of genetic information to train AI algorithms used in patient care—comes amid growing national concern over the commoditization of DNA data.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果